Quick Takeaways
- CVI Investments, Inc. filed SCHEDULE 13G for Annovis Bio, Inc. Common Stock, par value $0.0001 per share (ANVS).
- Disclosed ownership: 5.1%.
- Date of event: 03 Feb 2025.
CVI Investments, Inc. - 03 Feb 2025 SCHEDULE 13G Report for Annovis Bio, Inc. Common Stock, par value $0.0001 per share (ANVS)
- Filing Manager
- CVI Investments, Inc.
- Reporting Manager
- CVI Investments, Inc.
- Symbol
- ANVS
- Shares outstanding
- 19,607,843 shares
- Disclosed Ownership
- 1,000,000 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G
- Filing time
- 10 Feb 2025, 11:07:33 UTC
- Date of event
- 03 Feb 2025
- Next filing
- 12 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"CVI Investments, Inc. disclosed 5.1% ownership in Annovis Bio, Inc. Common Stock, par value $0.0001 per share (ANVS) on 03 Feb 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Feb 2025, 11:07.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. | 5.1% | 1,000,000 | 0 | 1,000,000 | /s/ Brian Sopinsky | Brian Sopinsky, Secretary of Heights Capital Management, Inc. | |
| Heights Capital Management, Inc. | 5.1% | 1,000,000 | 0 | 1,000,000 | /s/ Brian Sopinsky | Brian Sopinsky, Secretary |